RankingsPricing
  1. JP-listed companies
  2. SAPPORO CLINICAL LABORATORY INC.
  3. Financials
  4. Marketable securities, non-current

SAPPORO CLINICAL LABORATORY INC.JP:9776

Market cap
¥8.3B
P/E ratio
12.2x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndMarketable securities, non-current (Million JPY)YoY (%)
Mar 31, 2025235+11.93%
Mar 31, 2024210+40.18%
Mar 31, 2023150+5.17%
Mar 31, 2022142-19.33%
Mar 31, 2021177+31.91%
Mar 31, 2020134-18.65%
Mar 31, 2019165+23.79%
Mar 31, 2018133-3.13%
Mar 31, 2017137+19.80%
Mar 31, 2016115-24.78%
Mar 31, 2015152

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)